GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1025.15-17.55 (-1.68 %)
PREV CLOSE ( ) 1042.70
OPEN PRICE ( ) 1029.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21850
TODAY'S LOW / HIGH ( )1020.60 1038.70
52 WK LOW / HIGH ( )501 1068
NSE1026.40-15.4 (-1.48 %)
PREV CLOSE( ) 1041.80
OPEN PRICE ( ) 1032.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1026.40 (6)
VOLUME 762705
TODAY'S LOW / HIGH( ) 1020.15 1039.45
52 WK LOW / HIGH ( )500.35 1070
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.